Zydus Lifesciences Q4FY26 net profit rises 9%
Zydus board approved a buyback of up to Rs 1100 crore at Rs 1,150 per share, along with a 100 percent dividend for FY26. Zydus Lifesciences reported a rise in…
Chemists strike on May 20: Reasons behind today’s all-India strike
While major pharmacy chains and government medical outlets will remain operational, the strike highlights significant tensions within the industry that could impact access to medications nationwide. The All India Organisation…
AbbVie loses patent plea for Hep C drug
New Delhi: The Indian Patent Office has refused to grant a secondary patent to AbbVie for its blockbuster Hepatitis C drug combination glecaprevir/pibrentasvir, sold globally under the brand name Maviret.…
GSK’s Calpol a well-known trademark: High Court
New Delhi: In a relief to UK-headquartered GlaxoSmithKline Pharmaceuticals (GSK), the Delhi High Court has declared its pain and fever medicine ‘Calpol’ as a well-known trademark that has acquired extensive…
3 arrested for allegedly posing as doctors using forged MBBS degrees
Bhopal- A shocking case of medical fraud has come to light in Madhya Pradesh’s Damoh, where police have apprehended three men for allegedly posing as doctors at “Sanjeevani Clinics” operating…
Commissioner FDA reviews enforcement measures
Srinagar: Commissioner, Food & Drugs Administration (FDA), Jammu & Kashmir, Khalid Jahangir on Thursday held an introductory meeting with senior officers and field functionaries of Drug and Food Wing of the…
Karnataka High Court stays FSSAI advisory banning use of Ashwagandha leaves in health supplements
Karnataka High Court Ashwagandha ruling offers interim relief to supplement makers challenging the FSSAI advisory on Ashwagandha extracts. The Karnataka High Court has stayed an advisory issued by the Food…
Roche Pharma launches Tecentriq® SC, India’s first subcutaneous immunotherapy for lung cancer
Mumbai: Cancer patients and their caretakers in India often spend long, arduous hours in hospitals for conventional treatment. But now with the launch of the world’s first subcutaneous or under-the-skin…
CDSCO tighten drug quality oversight as substandard and spurious medicine cases rise in five years
New Delhi: The Central Drugs Standard Control Organization (CDSCO) and state drug regulatory authorities have intensified drug safety crackdown as substandard and spurious medicine cases have risen during the last…
Piramal Pharma Gets 3 USFDA Observations at US Facility
New Delhi: Piramal Pharma Limited has informed stock exchanges that the United States Food and Drug Administration (US FDA) conducted a Good Manufacturing Practices (GMP) inspection at the company’s Sellersville…
